IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FRACANZANI, ANNA LUDOVICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 26.266
NA - Nord America 21.440
AS - Asia 20.216
SA - Sud America 1.795
AF - Africa 461
OC - Oceania 99
Continente sconosciuto - Info sul continente non disponibili 20
Totale 70.297
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.649
GB - Regno Unito 9.250
CN - Cina 6.399
SG - Singapore 5.505
IT - Italia 5.315
DE - Germania 2.892
SE - Svezia 1.978
RU - Federazione Russa 1.977
HK - Hong Kong 1.724
VN - Vietnam 1.516
BR - Brasile 1.322
BD - Bangladesh 1.190
FR - Francia 994
NL - Olanda 975
IN - India 920
TR - Turchia 763
KR - Corea 691
UA - Ucraina 589
IE - Irlanda 585
FI - Finlandia 515
CA - Canada 503
JP - Giappone 351
PL - Polonia 285
EU - Europa 264
ID - Indonesia 263
CO - Colombia 170
DK - Danimarca 155
ES - Italia 153
MX - Messico 145
CI - Costa d'Avorio 141
AR - Argentina 115
TW - Taiwan 107
BE - Belgio 103
IQ - Iraq 92
AU - Australia 88
CH - Svizzera 88
PH - Filippine 76
AT - Austria 73
GR - Grecia 73
EG - Egitto 71
IR - Iran 71
ZA - Sudafrica 64
TH - Thailandia 63
MY - Malesia 58
UZ - Uzbekistan 50
PK - Pakistan 49
RO - Romania 47
CL - Cile 46
VE - Venezuela 44
EC - Ecuador 41
SA - Arabia Saudita 39
AE - Emirati Arabi Uniti 31
IL - Israele 30
KE - Kenya 30
DZ - Algeria 28
JO - Giordania 27
AZ - Azerbaigian 26
JM - Giamaica 25
CR - Costa Rica 24
CZ - Repubblica Ceca 24
NP - Nepal 24
MA - Marocco 23
NO - Norvegia 23
TN - Tunisia 23
PT - Portogallo 21
RS - Serbia 21
MO - Macao, regione amministrativa speciale della Cina 20
PY - Paraguay 18
PE - Perù 17
LT - Lituania 16
LU - Lussemburgo 16
LK - Sri Lanka 15
HU - Ungheria 14
PR - Porto Rico 14
BO - Bolivia 13
KZ - Kazakistan 13
OM - Oman 13
HN - Honduras 12
HR - Croazia 12
PA - Panama 12
ET - Etiopia 11
NG - Nigeria 11
NZ - Nuova Zelanda 11
SI - Slovenia 11
KG - Kirghizistan 10
SY - Repubblica araba siriana 10
TT - Trinidad e Tobago 10
AL - Albania 9
AM - Armenia 9
EE - Estonia 9
NI - Nicaragua 9
GE - Georgia 8
LB - Libano 8
SC - Seychelles 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
GT - Guatemala 7
LV - Lettonia 7
PS - Palestinian Territory 7
QA - Qatar 7
Totale 70.398
Salva come PNG Salva come JPEG
Città #
Southend 8.638
Singapore 3.193
Ashburn 2.185
Houston 1.581
Hong Kong 1.529
Milan 1.489
Chandler 1.373
Dallas 1.343
San Jose 1.270
Beijing 1.093
Seattle 803
Council Bluffs 724
Princeton 662
Frankfurt am Main 649
Wilmington 580
Dublin 571
Los Angeles 527
Fairfield 468
Jacksonville 443
New York 439
Ho Chi Minh City 434
Dearborn 409
Santa Clara 407
Hanover 394
Ann Arbor 389
Bengaluru 370
Nanjing 345
Lauterbourg 340
Hanoi 334
Munich 332
Boardman 330
Hefei 311
Moscow 292
Toronto 288
Guangzhou 280
Buffalo 279
Shanghai 277
Woodbridge 270
Redmond 266
Cambridge 243
Warsaw 238
Mountain View 231
Des Moines 226
Rome 208
Helsinki 207
Andover 195
The Dalles 195
Sakarya 188
Serra 175
Tokyo 171
Jakarta 161
Phoenix 147
São Paulo 147
Bogotá 140
Abidjan 139
Somerville 136
Chicago 128
Grafing 127
Istanbul 125
Jinan 121
Cangzhou 120
Seoul 116
Shenyang 116
Hangzhou 109
Tianjin 109
Columbus 107
Eitensheim 105
Changsha 102
Redwood City 99
Nanchang 92
Berlin 91
Fuzhou 91
Turin 86
Da Nang 85
Saint Petersburg 79
Atlanta 78
Shenzhen 74
Haiphong 73
Hebei 73
Dong Ket 71
Amsterdam 70
Naples 70
London 69
Brussels 68
Pisa 64
Nuremberg 63
Montreal 59
Wuhan 59
Brooklyn 55
Bitonto 50
Orem 50
Boston 49
Chengdu 49
Zhengzhou 49
Denver 48
Jiaxing 48
Palermo 46
Genoa 43
Fremont 42
Washington 42
Totale 42.524
Salva come PNG Salva come JPEG
Nome #
Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic Fatty liver disease 1.644
A second update on mapping the human genetic architecture of COVID-19 1.497
Mapping the human genetic architecture of COVID-19 1.142
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system 848
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 624
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 545
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 464
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis 449
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 440
PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma 429
The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation 424
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 407
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 365
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: an observational cohort study 363
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 355
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 349
Frontline antiviral therapy in a series of HCV-related low grade non-Hodgkin lymphoma 346
Use of high flow nasal cannula in patients with acute respiratory failure in general wards under intensivists supervision: a single center observational study 335
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression : An Observational Study in Patients with Nonalcoholic Fatty Liver Disease 332
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 328
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 320
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 319
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 319
MAFLD in COVID-19 patients: an insidious enemy 318
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 315
Epicardial Adipose Tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease 315
Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease 314
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 310
High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload 309
β-Klotho gene variation is associated with liver damage in children with NAFLD 306
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 305
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 303
Phenotyping congestion in patients with acutely decompensated heart failure with preserved and reduced ejection fraction: The Decongestion duRing therapY for acute decOmpensated heart failure in HFpEF vs HFrEF- DRY-OFF study 300
The hand arthropathy of hereditary hemochromatosis is strongly associated with iron overload 294
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 293
CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients 291
The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls 290
The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease 284
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 283
Adiponectin in nonalcoholic fatty liver disease : correlation with liver damage and PNPLA3 genotype 281
Vascular damage in patients with nonalcoholic fatty liver disease : Possible role of iron and ferritin 278
Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations 277
Carotid artery intima-media thickness in nonalcoholic fatty liver disease 274
Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study 271
Risk of NASH and severe fibrosis in patients with NAFLD and low visceral adiposity 270
Homozygosity for the PNPLA3/Adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease 270
Liver fat accumulation is associated with circulating PCSK9 levels 270
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease 267
α1-Antitrypsin mutations in NAFLD : high prevalence and association with altered iron metabolism but not with liver damage 258
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease 258
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 257
PNPLA3 I148M polymorphism, etiology, and clinical features of hepatocellular carcinoma 257
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD 257
Evaluation of three “beyond Baveno VI” criteria to safely spare endoscopies in compensated advanced chronic liver disease 254
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 253
Variables significantly associated with non alcoholic steatohepatitis (NASH) and fibrosis in patients with non alcoholic fatty liver disease (NAFLD) 252
Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease : a case control study 249
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma 249
Acquired hepatocerebral degeneration (AHD) : a peculiar neurological impairment in advanced chronic liver disease 248
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 248
High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation : preliminary results 248
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma 247
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis 246
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 245
Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis 244
Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma 243
Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up 243
Increased circulating adiponectin in males with chronic HCV hepatitis 240
The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with non-alcoholic fatty live 239
Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity 238
Progression of carotic atherosclerotic damage is related to alt values in patients with non alcoholic fatty liver disease 237
Echocardiographic epicardial fat thickness in non alcoholic fatty liver disease: a possible marker of metabolic syndrome and early vascular damage 237
PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease 236
Beta-globin mutations are associated with parenchymal siderosis and fibrosis severity in patients with nonalcoholic fatty liver disease 233
Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes : evidence in NAFLD patients and cell cultures 233
Risk of early atherosclerosis by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease and low visceral adiposity 231
Transmembrane 6 Superfamily Member 2 Gene Variant Disentangles Nonalcoholic Steatohepatitis From Cardiovascular Disease 231
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes: Mboat7 reduction and hepatic steatosis 229
Insulin related early andothelial dysfuction in patients with non alcoholic fatty liver disease (NAFLD) 228
Aberrant methylation of oncosuppressor genes detected in the peripheral blood of patients with chronic hepatitis C and hepatocellular carcinoma 228
Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C 227
Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients 226
Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study 226
Risk of early atherosclerosis by carotid artery intima- media thickness in patients with non alcoholic fatty liver disease and low visceral adiposity 225
Liver fat accumulation is associated with circulating PCSK9 225
The risk of severe liver disease in NAFLD with normal amino-transferase levels : a role for insulin and diabetes 224
Impact of natural neuromedin-B receptor variants on iron metabolism 224
Nutrients, genetic factors, and their interaction in non-alcoholic fatty liver disease and cardiovascular disease 224
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease 223
The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis 223
Hypermethylation of oncosuppressor genes in hereditary hemochromatosis 222
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 221
HFE gene mutations and oxidative stress influence serum ferritin, associated with vascular damage, in hemodialysis patients 219
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance 218
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease 217
Long-Term survival and risk of hepatocellular carcinoma occurrence in Italian patients with hereditary hemochromatosis 217
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown 217
Hepatic and adipose tissue transcriptome analysis highlights a commonly deregulated autophagic pathway in severe MASLD 216
Serum ferritin, is associated with iron availability, decreased anti-oxidant potemtial and HFE gene mutations, and a risk factor for cardiovascular damage in hemodialysis patients 216
Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis 215
Totale 32.153
Salva come PNG Salva come JPEG
Categoria #
all - tutte 183.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.649
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021551 0 0 0 0 0 0 0 0 0 0 0 551
2021/20224.992 380 198 267 471 351 360 421 353 595 402 421 773
2022/20235.068 626 533 457 467 602 947 128 362 495 75 252 124
2023/20243.800 142 324 208 252 930 255 231 183 126 259 415 475
2024/202510.585 412 1.022 333 1.013 680 456 527 1.044 699 1.028 1.133 2.238
2025/202623.244 2.122 1.738 2.573 1.754 2.013 1.387 2.705 1.459 2.372 1.745 2.727 649
Totale 73.198